To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dextrose Prolotherapy Improved Pain & Function in LE Patients Compared to HA at 12 Weeks

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2021

Dextrose Prolotherapy Improved Pain & Function in LE Patients Compared to HA at 12 Weeks

Vol: 10| Issue: 1| Number:22| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Injection Therapy in Patients with Lateral Epicondylalgia: Hyaluronic Acid or Dextrose Prolotherapy? A Single-Blind, Randomized Clinical Trial.

J Altern Complement Med . 2020 Dec;26(12):1169-1175

Contributing Authors:
H Apaydin Z Bazancir Z Altay

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirty-two patients with chronic lateral epicondylalgia (LE) were randomized to receive an injection with single dose pf high-molecular-weight hyaluronic acid (HA) or 3 doses of dextrose prolotherapy (DPT). The primary outcomes of interest included pain at rest, during movement, and at night on a Visual Analogue Scale (VAS), and physical function evaluated with the Quick-Disabilities of the Arm, S...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue